Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
How to Restart Weight Loss After a Tirzepatide Plateau IV
Your body needs time to adapt to GIP receptor activation
Newsletter Melden Sie sich an und erhalten Sie noch mehr Rabatte, Gutscheine und Infos Sitemap / Inhaltsverzeichnis Navigation Top-Apotheken Service Social Media Informationen
Long-Term Safety: What We Know and Don't Know What We Know (From TRIUMPH-4 and TRIUMPH-1) Up to 80 weeks of data: Side effects improve significantly after dose escalation (first 16 weeks hardest) No unexpected safety signals in either trial Dysesthesia doesn't worsen over time (stable) Discontinuation rates stabilize (most who stop do so in first 24 weeks) No deaths attributed to retatrutide in any completed trial TRIUMPH-1 104-week extension shows continued weight loss without new safety signals What We Don't Know Yet Longer-term questions (need 25+ years data): Does dysesthesia resolve completely if medication stopped
